Free Trial

Avanos Medical (AVNS) News Today

Avanos Medical logo
$15.49 +0.01 (+0.05%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$15.44 -0.04 (-0.27%)
As of 02/21/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Avanos Medical, Inc. stock logo
Avanos Medical (AVNS) to Release Earnings on Wednesday
Avanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Shares Down 6.3% - Here's What Happened
Avanos Medical (NYSE:AVNS) Stock Price Down 6.3% - Here's What Happened
Avanos Medical, Inc. stock logo
Rice Hall James & Associates LLC Makes New $989,000 Investment in Avanos Medical, Inc. (NYSE:AVNS)
Rice Hall James & Associates LLC bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 62,129 shares of the company's stock, v
Avanos Medical, Inc. stock logo
Paradice Investment Management LLC Buys 30,949 Shares of Avanos Medical, Inc. (NYSE:AVNS)
Paradice Investment Management LLC lifted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,293,198 shares of the company's stock after purchasing an add
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Sees Large Decline in Short Interest
Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 632,000 shares, a drop of 5.2% from the January 15th total of 666,900 shares. Currently, 1.4% of the company's stock are sold short. Based on an average daily trading volume, of 444,200 shares, the days-to-cover ratio is currently 1.4 days.
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Position Increased by Empowered Funds LLC
Empowered Funds LLC increased its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 141.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 153,834 shares of the company's stock after purchasing an additional 90,091 shares during the period. Em
Avanos Medical, Inc. stock logo
Avanos Medical (AVNS) Expected to Announce Earnings on Tuesday
Avanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Tuesday, February 18, Financial Modeling Prep reports.
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update
Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 681,400 shares, a decline of 6.4% from the December 31st total of 727,700 shares. Based on an average trading volume of 349,300 shares, the days-to-cover ratio is currently 2.0 days. Currently, 1.5% of the shares of the company are short sold.
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Stock Price Up 6.5% - Should You Buy?
Avanos Medical (NYSE:AVNS) Shares Up 6.5% - Should You Buy?
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Avanos Medical, Inc. stock logo
Tributary Capital Management LLC Purchases 246,379 Shares of Avanos Medical, Inc. (NYSE:AVNS)
Tributary Capital Management LLC raised its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 38.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 893,008 shares of the company's stock after purchasing an
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Issues Q4 2024 Earnings Guidance
Avanos Medical (NYSE:AVNS) updated its fourth quarter 2024 earnings guidance. The company provided EPS guidance of 0.380-0.430 for the period, compared to the consensus estimate of 0.400. The company also issued revenue guidance of $175.0 millionillion-$180.0 millionillion, compared to the consensus estimate of $177.2 millionillion.
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Updates Q4 Earnings Guidance
Avanos Medical (NYSE:AVNS) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.38-0.43 for the period, compared to the consensus estimate of $0.40. The company also issued revenue guidance of $175-180 millionillion, compared to the consensus estimate of $177.25 millionillion.
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Hits New 12-Month Low - Here's What Happened
Avanos Medical (NYSE:AVNS) Reaches New 52-Week Low - Here's Why
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Sees Large Volume Increase - Here's What Happened
Avanos Medical (NYSE:AVNS) Sees Unusually-High Trading Volume - Still a Buy?
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Sets New 52-Week Low - What's Next?
Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low - Time to Sell?
Avanos Medical, Inc. stock logo
Avanos Medical FY2026 EPS Estimate Lowered by Zacks Research
Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Equities research analysts at Zacks Research reduced their FY2026 earnings per share estimates for Avanos Medical in a report issued on Tuesday, December 31st. Zacks Research analyst R. Department now anticipates that the company will post earnings
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Sets New 1-Year Low - Here's Why
Avanos Medical (NYSE:AVNS) Reaches New 52-Week Low - Time to Sell?
Avanos Medical, Inc. stock logo
Barclays PLC Increases Stock Position in Avanos Medical, Inc. (NYSE:AVNS)
Barclays PLC increased its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 446.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 96,194 shares of the company's stock after purchasing a
Avanos Medical Inc.
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low - What's Next?
Avanos Medical (NYSE:AVNS) Sets New 1-Year Low - What's Next?
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Hits New 12-Month Low - What's Next?
Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low - Time to Sell?
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Sees Significant Increase in Short Interest
Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 614,500 shares, an increase of 11.3% from the November 15th total of 552,300 shares. Approximately 1.4% of the company's stock are sold short. Based on an average trading volume of 254,300 shares, the short-interest ratio is currently 2.4 days.
Avanos Medical, Inc. stock logo
Fmr LLC Boosts Holdings in Avanos Medical, Inc. (NYSE:AVNS)
Fmr LLC lifted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 34.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 133,844 shares of the company's stock after purchasing an additional 34,421 shar
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lessened its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 7.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 523,494 shares of the company's stock after selling 44,734 shares during the quarter. Charles S
Avanos Medical, Inc. stock logo
Zacks Research Expects Higher Earnings for Avanos Medical
Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Research analysts at Zacks Research lifted their Q3 2025 earnings per share estimates for Avanos Medical in a report issued on Tuesday, December 3rd. Zacks Research analyst R. Department now expects that the company will earn $0.43 per share for th
Avanos Medical Appoints Interim CFO Warren Machan
Avanos Medical, Inc. stock logo
Zacks Research Cuts Earnings Estimates for Avanos Medical
Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Research analysts at Zacks Research cut their Q3 2025 earnings estimates for shares of Avanos Medical in a note issued to investors on Wednesday, November 20th. Zacks Research analyst R. Department now expects that the company will post earnings pe
Avanos Medical, Inc. stock logo
Empowered Funds LLC Sells 127,491 Shares of Avanos Medical, Inc. (NYSE:AVNS)
Empowered Funds LLC trimmed its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 66.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 63,743 shares of the company's stock after s
Avanos Medical, Inc. stock logo
Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Cornercap Investment Counsel Inc.
Cornercap Investment Counsel Inc. lessened its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 52.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,769 shares of the company's stock after
Avanos Medical Launches New CORGRIP® SR
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Lowered to Buy Rating by StockNews.com
StockNews.com lowered shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday.
Avanos Medical Reports Q3 Results and CEO Retirement
Avanos Medical Announces CEO Retirement and Interim Appointment
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Shares Gap Down - Should You Sell?
Avanos Medical (NYSE:AVNS) Shares Gap Down - What's Next?
Avanos Medical, Inc. stock logo
Avanos Medical (NYSE:AVNS) Updates FY 2024 Earnings Guidance
Avanos Medical (NYSE:AVNS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.300-1.350 for the period, compared to the consensus estimate of 1.390. The company also issued revenue guidance of $683.0 millionillion-$688.0 millionillion, compared to the consensus estimate of $695.2 millionillion.
Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

AVNS Media Mentions By Week

AVNS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVNS
News Sentiment

0.80

0.60

Average
Medical
News Sentiment

AVNS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVNS Articles
This Week

8

2

AVNS Articles
Average Week

Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:AVNS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners